News | March 18, 2023
Eiko LifeSciences to acquire 5% stake in Vivacious Pharmatex
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
A funding to expand operations and provide better patient care
Proposed combination enhances Pfizer’s position as a leading company in oncology
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
The inspection concluded with no observations
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Digital success is contingent on the way a company organizes itself around technology
Subscribe To Our Newsletter & Stay Updated
